tiprankstipranks
Immunotech Biopharm Ltd (HK:6978)
:6978
Hong Kong Market
6978
Immunotech Biopharm Ltd
RESEARCH TOOLSreports
Want to see HK:6978 full AI Analyst Report?

Immunotech Biopharm Ltd (6978) Financial Statements

1 Followers

Immunotech Biopharm Ltd Financial Overview

Immunotech Biopharm Ltd's market cap is currently HK$518.70M. The company's EPS TTM is HK$-0.42; its P/E ratio is -3.95; Immunotech Biopharm Ltd is scheduled to report earnings on March 20, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Gross Profit¥ -53.87M¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Operating Income¥ -169.36M¥ -198.78M¥ -230.55M¥ -273.93M¥ -344.86M
EBITDA¥ -115.49M¥ -148.68M¥ -178.83M¥ -231.11M¥ -324.33M
Net Income¥ -224.81M¥ -186.91M¥ -334.82M¥ -318.11M¥ -354.22M
Balance Sheet
Cash & Short-Term Investments¥ 154.63M¥ 57.49M¥ 176.97M¥ 79.46M¥ 353.34M
Total Assets¥ 603.20M¥ 564.04M¥ 846.28M¥ 879.44M¥ 1.10B
Total Debt¥ 440.26M¥ 384.56M¥ 784.01M¥ 149.81M¥ 111.05M
Net Debt¥ 385.78M¥ 337.60M¥ 731.85M¥ 91.36M¥ -242.29M
Total Liabilities¥ 569.01M¥ 580.50M¥ 675.39M¥ 373.07M¥ 274.51M
Stockholders' Equity¥ -13.93M¥ -13.30M¥ 173.62M¥ 508.44M¥ 822.26M
Cash Flow
Free Cash Flow¥ -111.92M¥ -153.81M¥ -186.17M¥ -277.49M¥ -435.89M
Operating Cash Flow¥ -97.29M¥ -125.74M¥ -163.63M¥ -180.92M¥ -254.65M
Investing Cash Flow¥ -98.07M¥ 141.10M¥ -116.60M¥ 23.38M¥ -328.21M
Financing Cash Flow¥ 203.20M¥ -20.59M¥ 273.92M¥ -36.06M¥ -11.00M
Currency in CNY

Immunotech Biopharm Ltd Earnings and Revenue History

Income Statement >

Immunotech Biopharm Ltd Debt to Assets

Balance Sheet >

Immunotech Biopharm Ltd Cash Flow

Cash Flow >

Immunotech Biopharm Ltd Forecast EPS vs Actual EPS

Earnings >